Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Emulsion and liposome-based adjuvanted R21 vaccine formulations mediate protection against malaria through distinct immune mechanisms.

Reinke S. et al, (2023), Cell reports. Medicine

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases.

Luchner M. et al, (2021), Pharmaceutics, 13

Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology

Codd AS. et al, (2021), Oxford Open Immunology, 2

T cell phenotypes in COVID-19 - a living review

Hanna SJ. et al, (2021), Oxford Open Immunology, 2

The role and uses of antibodies in COVID-19 infections: a living review

Scourfield DO. et al, (2021), Oxford Open Immunology, 2

Mucosal immune responses in COVID19 - a living review.

Pearson CF. et al, (2021), Oxf Open Immunol, 2

Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants.

Reinke S. et al, (2020), Vaccines, 8

Technological Approaches for Improving Vaccination Compliance and Coverage.

Lemoine C. et al, (2020), Vaccines, 8

Investigating the Effect of Encapsulation Processing Parameters on the Viability of Therapeutic Viruses in Electrospraying

Sanders T. et al, (2020), Pharmaceutics, 12, 388 - 388

Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease

Elshina E. et al, (2019), Vaccine, 37, 502 - 509

Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults

Coughlan L. et al, (2018), EBioMedicine, 29, 146 - 154

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria

Milicic A. et al, (2017), Scientific Reports, 7

Development of persistent gastrointestinal S. aureus carriage in mice

Flaxman A. et al, (2017), Scientific Reports, 7

The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens

Diemen PMV. et al, (2017), Scientific Reports, 7

Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy

Walters AA. et al, (2015), Journal of Pharmacy and Pharmacology, 67, 400 - 408

Immune responses associated with homologous protection conferred by commercial vaccines for control of avian pathogenic Escherichia coli in turkeys

Sadeyen J-R. et al, (2015), Veterinary Research, 46, 5 - 5

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice

Warimwe GM. et al, (2013), Virology Journal, 10

A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years

Antrobus RD. et al, (2012), PLoS ONE, 7, e48322 - e48322

Mixed Vector Immunization With Recombinant Adenovirus and MVA Can Improve Vaccine Efficacy While Decreasing Antivector Immunity

Reyes-Sandoval A. et al, (2012), Molecular Therapy, 20, 1633 - 1647

Small Cationic DDA:TDB Liposomes as Protein Vaccine Adjuvants Obviate the Need for TLR Agonists in Inducing Cellular and Humoral Responses

Milicic A. et al, (2012), PLoS ONE, 7, e34255 - e34255

Load More

Include forthcoming?